Global Viral Vectors and Plasmid DNA Manufacturing Market Insights and Forecast to 2028

Global Viral Vectors and Plasmid DNA Manufacturing Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Plasmid DNA
1.2.3 Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2017-2028)
2.2 Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Region
2.2.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
2.3.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
2.3.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
2.3.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
2.3.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue
3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2021
3.5 Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Area Served
3.6 Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
3.7 Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Type
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2023-2028)
5 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Application
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
6.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
6.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
6.2.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
6.2.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
6.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
6.3.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
6.3.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
6.4.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022)
6.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
7.2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
7.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
7.2.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
7.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
7.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
7.3.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
7.4.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022)
7.4.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
8.2.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
8.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
8.3.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
8.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region
8.4.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
9.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
9.2.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
9.2.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
9.2.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
9.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
9.3.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
9.3.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
9.3.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
9.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
9.4.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022)
9.4.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
10.2.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
10.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
10.3.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
10.4 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
10.4.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Details
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Introduction
11.1.4 BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.1.5 BioReliance Recent Developments
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Details
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Introduction
11.2.4 Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.2.5 Cobra Biologics Recent Developments
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Details
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.3.5 Oxford BioMedica Recent Developments
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Introduction
11.4.4 UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.4.5 UniQure Recent Developments
11.5 FinVector
11.5.1 FinVector Company Details
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Introduction
11.5.4 FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.5.5 FinVector Recent Developments
11.6 MolMed
11.6.1 MolMed Company Details
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Introduction
11.6.4 MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.6.5 MolMed Recent Developments
11.7 MassBiologics
11.7.1 MassBiologics Company Details
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Introduction
11.7.4 MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.7.5 MassBiologics Recent Developments
11.8 Richter-Helm
11.8.1 Richter-Helm Company Details
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Introduction
11.8.4 Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.8.5 Richter-Helm Recent Developments
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Details
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.10 Lonza
11.10.1 Lonza Company Details
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
11.10.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.10.5 Lonza Recent Developments
11.11 Aldevron
11.11.1 Aldevron Company Details
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Introduction
11.11.4 Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.11.5 Aldevron Recent Developments
11.12 Eurogentec
11.12.1 Eurogentec Company Details
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Introduction
11.12.4 Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.12.5 Eurogentec Recent Developments
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Details
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.13.5 Cell and Gene Therapy Catapult Recent Developments
11.14 Biovian
11.14.1 Biovian Company Details
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Introduction
11.14.4 Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.14.5 Biovian Recent Developments
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
11.16 VGXI
11.16.1 VGXI Company Details
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Introduction
11.16.4 VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.16.5 VGXI Recent Developments
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Details
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Introduction
11.17.4 PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
11.17.5 PlasmidFactory Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Plasmid DNA
Table 3. Key Players of Viral Vectors
Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2017-2022)
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2023-2028)
Table 10. Viral Vectors and Plasmid DNA Manufacturing Market Trends
Table 11. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
Table 12. Viral Vectors and Plasmid DNA Manufacturing Market Challenges
Table 13. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
Table 14. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players (2017-2022)
Table 16. Global Top Viral Vectors and Plasmid DNA Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2021)
Table 17. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
Table 21. Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2017-2022)
Table 25. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2023-2028)
Table 27. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application (2017-2022)
Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application (2023-2028)
Table 31. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 61. BioReliance Company Details
Table 62. BioReliance Business Overview
Table 63. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product
Table 64. BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 65. BioReliance Recent Developments
Table 66. Cobra Biologics Company Details
Table 67. Cobra Biologics Business Overview
Table 68. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 69. Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 70. Cobra Biologics Recent Developments
Table 71. Oxford BioMedica Company Details
Table 72. Oxford BioMedica Business Overview
Table 73. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product
Table 74. Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 75. Oxford BioMedica Recent Developments
Table 76. UniQure Company Details
Table 77. UniQure Business Overview
Table 78. UniQure Viral Vectors and Plasmid DNA Manufacturing Product
Table 79. UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 80. UniQure Recent Developments
Table 81. FinVector Company Details
Table 82. FinVector Business Overview
Table 83. FinVector Viral Vectors and Plasmid DNA Manufacturing Product
Table 84. FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 85. FinVector Recent Developments
Table 86. MolMed Company Details
Table 87. MolMed Business Overview
Table 88. MolMed Viral Vectors and Plasmid DNA Manufacturing Product
Table 89. MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 90. MolMed Recent Developments
Table 91. MassBiologics Company Details
Table 92. MassBiologics Business Overview
Table 93. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 94. MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 95. MassBiologics Recent Developments
Table 96. Richter-Helm Company Details
Table 97. Richter-Helm Business Overview
Table 98. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product
Table 99. Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 100. Richter-Helm Recent Developments
Table 101. FUJIFILM Diosynth Biotechnologies Company Details
Table 102. FUJIFILM Diosynth Biotechnologies Business Overview
Table 103. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product
Table 104. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 105. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 106. Lonza Company Details
Table 107. Lonza Business Overview
Table 108. Lonza Viral Vectors and Plasmid DNA Manufacturing Product
Table 109. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 110. Lonza Recent Developments
Table 111. Aldevron Company Details
Table 112. Aldevron Business Overview
Table 113. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product
Table 114. Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 115. Aldevron Recent Developments
Table 116. Eurogentec Company Details
Table 117. Eurogentec Business Overview
Table 118. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product
Table 119. Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 120. Eurogentec Recent Developments
Table 121. Cell and Gene Therapy Catapult Company Details
Table 122. Cell and Gene Therapy Catapult Business Overview
Table 123. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product
Table 124. Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 125. Cell and Gene Therapy Catapult Recent Developments
Table 126. Biovian Company Details
Table 127. Biovian Business Overview
Table 128. Biovian Viral Vectors and Plasmid DNA Manufacturing Product
Table 129. Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 130. Biovian Recent Developments
Table 131. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 132. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 133. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product
Table 134. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 135. Thermo Fisher Scientific (Brammer Bio) Recent Developments
Table 136. VGXI Company Details
Table 137. VGXI Business Overview
Table 138. VGXI Viral Vectors and Plasmid DNA Manufacturing Product
Table 139. VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 140. VGXI Recent Developments
Table 141. PlasmidFactory Company Details
Table 142. PlasmidFactory Business Overview
Table 143. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product
Table 144. PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
Table 145. PlasmidFactory Recent Developments
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2021 VS 2028
Figure 2. Plasmid DNA Features
Figure 3. Viral Vectors Features
Figure 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2021 VS 2028
Figure 5. Cancers Case Studies
Figure 6. Inherited Disorders Case Studies
Figure 7. Viral Infections Case Studies
Figure 8. Others Case Studies
Figure 9. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2021 VS 2028
Figure 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2021
Figure 14. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2021
Figure 16. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2017-2028)
Figure 18. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2017-2028)
Figure 19. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Country (2017-2028)
Figure 20. United States Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2017-2028)
Figure 24. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2017-2028)
Figure 25. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Country (2017-2028)
Figure 26. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Viral Vectors and Plasmid DN

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs